MIRA INFORM REPORT

 

 

Report No. :

329640

Report Date :

06.07.2015

 

IDENTIFICATION DETAILS

 

Name :

MOREPEN LABORATORIES LIMITED

 

 

Registered Office :

Morepen Village, Nalagarh Road, Near Baddi, District Solan – 173205, Himachal Pradesh

Tel. No.:

91-11-23324443,23712025

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

01.12.1984

 

 

Com. Reg. No.:

006028

 

 

Capital Investment / Paid-up Capital :

Rs.2096.107 Million

 

 

CIN No.:

[Company Identification No.]

L24231HP1984PLC006028

 

 

IEC No.:

2288001348

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

PTLM11889D

 

 

PAN No.:

[Permanent Account No.]

AABCM1083B

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer and Exporter of pharmaceutical products.

 

 

No. of Employees :

1010 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (14)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Poor

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having poor track.

 

The company possesses weak financial risk profile marked by losses incurred from its operational activities and weak liquidity and debt protection metrics of the company.

 

Moreover, it is also to be noted that company has listed with RBI defaulter and defaulted hefty amount with serval banks.

 

Business is active. Payments are reported to be slow.

 

In view of weak financial and managerial profile, the company can be considered for business dealings on safe and secured trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name has been found enlisted as a defaulter in the publicly available RBI Defaulters’ list and the details of the same are as under :

 

BANK

BRANCH

QUARTER

BORROWER NAME

DIRECTORS NAME

OUT STANDING AMOUNT

BANK OF BARODA

CBB NEW DELH

31-12-05

MOREPEN LABORATORIES LIMITED

SUSHIL SURI, J.S.PAL, ARUN SURI, N.H.BALTER, P.S.PRITAM, JUJHAR SINGH, V.K.SAXENA, KANTA SURI

555.800

BANK OF BARODA

CBB NEW DELH

31-03-06

MOREPEN LABORATORIES LIMITED

V.K.SAXENA, P.S.PRITAM, N.H.BALTER, J.S.PAL, JUJHAR SINGH, ARUN SURI, SUSHIL SURI, KANTA SURI MRS

555.800

BANK OF BARODA

CFS, NEW DELHI

30-06-06

MOREPEN LABORATORIES LIMITED

KANTA SURI, JUJHAR SINGH, ARUN SURI, SUSHIL SURI, V.K.SAXENA, P.S.PRITAM, N.H.BALTER, J.S.PAL

473.700

BANK OF BARODA

CFS, NEW DELHI

30-06-07

MOREPEN LABORATORIES LIMITED

J.S.PAL, SUSHIL SURI, ARUN SURI, N.H.BALTER, V.K.SAXENA, P.S.PRITAM, JUJHAR SINGH, KANTA SURI

473.800

BANK OF BARODA

CFS, NEW DELHI

30-09-07

MOREPEN LABORATORIES LIMITED

KANTA SURI, SUSHIL SURI, J.S.PAL, ARUN SURI, N.H.BALTER, JUJHAR SINGH, P.S.PRITAM, V.K.SAXENA

473.800

BANK OF BARODA

CFS, NEW DELHI

30-09-06

MOREPEN LABORATORIES LIMITED

 

473.700

BANK OF BARODA

CFS, NEW DELHI

31-12-06

MOREPEN LABORATORIES LIMITED

KANTA SURI, J.S.PAL, SUSHIL SURI, ARUN SURI, N.H.BALTER, JUJHAR SINGH, V.K.SAXENA, P.S.PRITAM

473.800

BANK OF BARODA

CFS, NEW DELHI

31-03-07

MOREPEN LABORATORIES LIMITED

J.S.PAL, SUSHIL SURI, ARUN SURI, V.K.SAXENA, P.S.PRITAM, JUJHAR SINGH, N.H.BALTER, KANTA SURI

473.800

SOCIETE GENERALE

DELHI

31-03-04

MOREPEN LABORATORIES LIMITED

SUNIL GULATI, MANOJ JOSHI, PS PRITAM, SUSHIL KUMAR SURI

67.500

UNIT TRUST OF INDIA LTD

MAIN BRANCH

30-06-04

MOREPEN LABORATORIES LIMITED

P.S.PRITAM, R.D.DAMLE, DEEPAK GUPTA, MANOJ JOSHI, SUNIL GULATI, SUSHIL SURI

82.100

UNIT TRUST OF INDIA LTD

MAIN BRANCH

31-03-04

MOREPEN LABORATORIES LIMITED

SUNIL GULATI, DEEPAK GUPTA, MANOJ JOSHI, SUSHIL SURI, R.D.DAMLE, P.S.PRITAM

64.100

UNIT TRUST OF INDIA LTD

MAIN BRANCH

30-09-04

MOREPEN LABORATORIES LIMITED

R.D.DAMLE, DEEPAK GUPTA, P.S.PRITAM, MANOJ JOSHI, SUSHIL SURI, SUNIL GULATI

82.800

UNIT TRUST OF INDIA LTD

MAIN OFFICE

30-09-03

MOREPEN LABORATORIES LIMITED

DEEPAK GUPTA, MANOJ JOSHI, P.S.PRITAM, R.D.DAMLE, SUNIL GULATI, SUSHIL SURI

45.000

UNIT TRUST OF INDIA LTD

MAIN OFFICE

31-12-03

MOREPEN LABORATORIES LIMITED

DEEPAK GUPTA, MANOJ JOSHI, P.S.PRITAM, R.D.DAMLE, SUNIL GULATI, SUSHIL SURI

45.000

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

30-06-10

MOREPEN LABORATORIES LIMITED

BHUPENDER RAJ WADHWA, MANOJ JOSHI, ARUN KUMAR SINHA, SUSHIL SURI, SUKHCHARAN SINGH

98.900

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

31-12-10

MOREPEN LABORATORIES LIMITED

SUSHIL SURI, SUKHCHARAN SINGH, BHUPENDER RAJ WADHWA, ARUN KUMAR SINHA, MANOJ JOSHI

98.900

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

30-09-11

MOREPEN LABORATORIES LIMITED

ARUN KUMAR SINHA, SUSHIL SURI, SUKHCHARAN SINGH, BHUPENDER RAJ WADHWA, MANOJ JOSHI

75.100

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

31-12-11

MOREPEN LABORATORIES LIMITED

SUSHIL SURI, BHUPENDER RAJ WADHWA, MANOJ JOSHI, ARUN KUMAR SINHA, SUKHCHARAN SINGH

75.100

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

31-03-10

MOREPEN LABORATORIES LIMITED

MANOJ JOSHI, SUSHIL SURI, SUKHCHARAN SINGH, BHUPENDER RAJ WADHWA, ARUN KUMAR SINHA

98.900

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

31-12-09

MOREPEN LABORATORIES LIMITED

MANOJ JOSHI, SUKHCHARAN SINGH, SUSHIL SURI, ARUN KUMAR SINHA, BHUPENDER RAJ WADHWA

98.900

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

30-09-09

MOREPEN LABORATORIES LIMITED

SUKHCHARAN SINGH, ARUN KUMAR SINHA, BHUPENDER RAJ WADHWA, MANOJ JOSHI, SUSHIL SURI

98.900

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

30-09-07

MOREPEN LABORATORIES LIMITED

BHUPENDER RAJ WADHWA, MANOJ JOSHI, SUSHIL SURI, SUKHCHARAN SINGH, ARUN KUMAR SINHA

100.100

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

31-12-07

MOREPEN LABORATORIES LIMITED

BHUPENDER RAJ WADHWA, MANOJ JOSHI, SUSHIL SURI,, ARUN KUMAR SINHA, SUKHCHARAN SINGH

100.100

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

31-03-08

MOREPEN LABORATORIES LIMITED

ARUN KUMAR SINHA, MANOJ JOSHI, BHUPENDER RAJ WADHWA, SUKHCHARAN SINGH, SUSHIL SURI

100.100

SPECIFIED UNDERTAKING OF UNIT TRUST OF INDIA

MUMBAI

31-03-09

MOREPEN LABORATORIES LIMITED

ARUN KUMAR SINHA, MANOJ JOSHI, BHUPENDER RAJ WADHWA, SUSHIL SURI, SUKHCHARAN SINGH

98.900

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

30-06-04

MOREPEN LABORATORIES LIMITED

SUSHIL SURI, J.S.PAL, SUNIL GULATI, ARUN SURI, KANTA SURI, R.D.DAMLE, DEEPAK GUPTA, P.S.PRITAM, MANOJ JOSHI, JUJHAR SINGH, N.H.BHATTER

143.600

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

31-12-03

MOREPEN LABORATORIES LIMITED

ARUN SURI, DEEPAK GUPTA, J.S.PAL, JUJHAR SINGH, KANTA SURI, MANOJ JOSHI, N.H.BHATTER, P.S.PRITAM, R.D.DAMLE, SUNIL GULATI, SUSHIL SURI

143.600

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

30-09-04

MOREPEN LABORATORIES LIMITED

R.D.DAMLE, JUJHAR SINGH, J.S.PAL, ARUN SURI, DEEPAK GUPTA, SUNIL GULATI, SUSHIL SURI, KANTA SURI, P.S.PRITAM, MANOJ JOSHI, N.H.BHATTER

143.600

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

31-03-04

MOREPEN LABORATORIES LIMITED

JUJHAR SINGH, R.D.DAMLE, SUNIL GULATI, SUSHIL SURI, KANTA SURI, ARUN SURI, N.H.BHATTER, P.S.PRITAM, MANOJ JOSHI, DEEPAK GUPTA, J.S.PAL

151.800

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

31-03-09

Morepen Laboratories Limited

Sushil Suri

97.079

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

30-06-09

Morepen Laboratories Limited

Sushil Suri

97.079

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

30-09-09

Morepen Laboratories Limited

Sushil Suri

97.079

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

31-12-09

Morepen Laboratories Limited

Sushil Suri

97.079

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

31-03-10

Morepen Laboratories Limited

Sushil Suri

1.994

BANK OF BAHRAIN & KUWAIT B.S.C.

MUMBAI

30-06-10

Morepen Laboratories Limited

Sushil Suri

0.000

SOCIETE GENERALE

MUMBAI

31-03-05

MOREPEN LABORATORIES LIMITED

SUSHIL SURI

53.141

SOCIETE GENERALE

MUMBAI

30-09-04

MOREPEN LABORATORIES LIMITED

SUSHIL SURI

52.713

SOCIETE GENERALE

MUMBAI

31-12-04

MOREPEN LABORATORIES LIMITED

SUSHIL SURI

52.713

SOCIETE GENERALE

MUMBAI

30-09-05

MOREPEN LABORATORIES LIMITED

SUSHIL SURI

52.475

SOCIETE GENERALE

MUMBAI

31-12-05

MOREPEN LABORATORIES LIMITED

SUSHIL SURI

53.141

SOCIETE GENERALE

MUMBAI

31-03-06

MOREPEN LABORATORIES LIMITED

SUSHIL SURI

53.141

UNIT TRUST OF INDIA LTD

MUMBAI

31-03-05

MOREPEN LABORATORIES LIMITED

DEEPAK GUPTA, MANOJ JOSHI, SUNIL GULATI, SUSHIL SURI, P.S.PRITAM, R.D.DAMLE

100.135

SBI COMMERCIAL AND INTERNATIONAL BANK LTD.

NARIMAN POINT

31-12-03

MOREPEN LABORATORIES LIMITED

ARUN SURI, DEEPAK GUPTA, JUJHAR SINGH, KANTA SURI, MAMTA SURI, MANOJ JOSHI, N. H. BHATTER, P. S. PRITAM, SANJAY SURI, SUSHIL SURI

105.200

SBI COMMERCIAL AND INTERNATIONAL BANK LTD.

NARIMAN POINT

30-06-03

MOREPEN LABORATORIES LIMITED

ARUN SURI, DEEPAK GUPTA, JUJHAR SINGH, KANTA SURI, MAMTA SURI, MANOJ JOSHI, N. H. BHATTER, P. S. PRITAM, SANJAY SURI, SUSHIL SURI

105.200

SBI COMMERCIAL AND INTERNATIONAL BANK LTD.

NARIMAN POINT

30-09-03

MOREPEN LABORATORIES LIMITED

ARUN SURI, DEEPAK GUPTA, JUJHAR SINGH, KANTA SURI, MAMTA SURI, MANOJ JOSHI, N. H. BHATTER, P. S. PRITAM, SANJAY SURI, SUSHIL SURI

105.200

CHINATRUST COMMERCIAL BANK LTD.

NEW DELHI

31-12-05

Morepen Laboratories Limited

P.S.Pritam, Sushil Suri, Sunil Gulati, Manoj Joshi

0.112

CHINATRUST COMMERCIAL BANK LTD.

NEW DELHI

30-09-05

Morepen Laboratories Limited

P.S.Pritam, Sunil Gulati, Manoj Joshi, Sushil Suri

85.887

THE SOUTH INDIAN BANK LIMITED

NEW DELHI C.P.

30-06-05

MOREPEN LABORATORIES LIMITED

ARUN SURI, SUSHIL SURI, V K SAXENA, JUJMAR SINGH, J S PAL, KANTHA SURI, MANOJ JOSHI, MAMTA SURI

131.500

THE SOUTH INDIAN BANK LIMITED

NEW DELHI C.P.

30-09-05

MOREPEN LABORATORIES LIMITED

J S PAL, ARUN SURI, SUSHIL SURI, JUJMAR SINGH, KANTHA SURI, MANOJ JOSHI, V K SAXENA, MAMTA SURI

131.500

THE SOUTH INDIAN BANK LIMITED

NEW DELHI C.P.

31-03-06

MOREPEN LABORATORIES LIMITED

KANTHA SURI, JUJMAR SINGH, MANOJ JOSHI, MAMTA SURI, J S PAL, SUSHIL SURI, V K SAXENA, ARUN SURI

131.500

THE SOUTH INDIAN BANK LIMITED

NEW DELHI C.P.

31-12-05

MOREPEN LABORATORIES LIMITED

SUSHIL SURI, V K SAXENA, J S PAL, ARUN SURI, KANTHA SURI, JUJMAR SINGH, MANOJ JOSHI, MAMTA SURI

131.500

THE SOUTH INDIAN BANK LIMITED

NEW DELHI C.P.

30-09-06

MOREPEN LABORATORIES LIMITED

 

131.500

THE SOUTH INDIAN BANK LIMITED

NEW DELHI C.P.

31-12-06

MOREPEN LABORATORIES LIMITED

SUSHIL SURI, V K SAXENA, J S PAL, ARUN SURI, MANOJ JOSHI, KANTHA SURI, JUJMAR SINGH, MAMTA SURI

131.500

THE SOUTH INDIAN BANK LIMITED

NEW DELHI C.P.

30-06-06

MOREPEN LABORATORIES LIMITED

V K SAXENA, MAMTA SURI, KANTHA SURI, ARUN SURI, SUSHIL SURI, JUJMAR SINGH, J S PAL, MANOJ JOSHI

131.500

THE SOUTH INDIAN BANK LIMITED

NEW DELHI C.P.

30-06-07

MOREPEN LABORATORIES LIMITED

MANOJ JOSHI, MAMTA SURI, V K SAXENA, KANTHA SURI, J S PAL, SUSHIL SURI, ARUN SURI, JUJMAR SINGH

131.500

 

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

 

INFORMATION PARTED BY

 

Name :

Mr. Rajiv Jain

Designation :

Accounts Department

Contact No.:

91-1792-233285

Date :

01.07.2015

 

 

LOCATIONS

 

Registered Office :

Morepen Village, Nalagarh Road, Near Baddi, District Solan – 173205, Himachal Pradesh, India

Tel. No.:

91-1795-276201-03

Fax No.:

91-1795-276204

E-Mail :

Home Health Devices : devices.customercare@morepen.com 

API’s  : sales@morepen.com

Formulations   :medicuspmt@morepen.com

OTC / Dr Morepen  :mktg@morepen.com

Finance :corporatefinance@morepen.com

Fixed Deposit  :   fixeddeposit@morepen.com 

Career humanresource@morepen.com

investors@morepen.com

plants@morepen.com

Website :

http://www.morepen.com

Location :

Owned [Commercial]

 

 

Corporate Office :

409, Antriksh Bhawan, 22 Kasturba Gandhi Marg, New Delhi - 110 001, India

Tel. No.:

91-11-23324443,23712025

Fax No.:

91-11 23722422

E-Mail :

corporate@morepen.com

 

 

Factory 1 :

Located at Masulkhanna, Himachal Pradesh, India

Village Masulkhana, District Solan, Himachal Pradesh, India

Tel. No.:

91-1792-233284

Fax No.:

91-1792-232606

 

 

Factory 2 :

Located at Baddi, Himachal Pradesh, India

Tel. No.:

91-1795-246408/03

Fax No.:

91-1795-244591

 

 

Factory 3 :

Sector-2, Parwanoo, District Solan, Himachal Pradesh, India

 

 

USA Office :

666 Plainsboro Road, Suite 215, Plainsboro,  New Jersey - 08536

Tel. No.:

+609 716 6300

Fax No.:

+609 716 6301

E-Mail :

ussales@morepen.com

 

 

DIRECTORS

 

AS ON 31.03.2014

 

Name :

Mr. Sushil Suri

Designation :

Chairman and Managing Director

 

 

Name :

Dr. Arun Kumar Sinha

Designation :

Director

 

 

Name :

Mr. Manoj Joshi

Designation :

Director

 

 

Name :

Mr. Bhupender Raj Wadhwa

Designation :

Director

 

 

Name :

Mr. Sukhcharan Singh

Designation :

Director

Date of Birth/Age :

07.09.1942

Qualification :

B.A., Retired Inspector General of Police

Date of Appointment :

15.06.2005

 

 

KEY EXECUTIVES

 

Name :

Mr. Rajiv Jain

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2015

 

Category of Shareholder

Total No. of Shares

Total Shareholding as a % of Total No. of Shares

 

(A) Shareholding of Promoter and Promoter Group

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

41241750

9.17

http://www.bseindia.com/include/images/clear.gifBodies Corporate

114129838

25.37

http://www.bseindia.com/include/images/clear.gifSub Total

155371588

34.54

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

155371588

34.54

 

 

 

(B) Public Shareholding

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

6367940

1.42

http://www.bseindia.com/include/images/clear.gifInsurance Companies

22484570

5.00

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

48897500

10.87

http://www.bseindia.com/include/images/clear.gifSub Total

77750010

17.28

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

22828279

5.07

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

Individual shareholders holding nominal share capital up to Rs. 0.100 Million

148678943

33.05

Individual shareholders holding nominal share capital in excess of Rs. 0.100 Million

26844865

5.97

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

18352518

4.08

http://www.bseindia.com/include/images/clear.gifNRIs/OCBs

14162346

3.15

http://www.bseindia.com/include/images/clear.gifClearing Members

3917542

0.87

http://www.bseindia.com/include/images/clear.gifTrusts

272630

0.06

http://www.bseindia.com/include/images/clear.gifSub Total

216704605

48.18

Total Public shareholding (B)

294454615

65.46

 

 

 

Total (A)+(B)

449826203

100.00

 

 

 

(C) Shares held by Custodians and against which Depository Receipts have been issued

 

 

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

 

 

 

Total (A)+(B)+(C)

449826203

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of pharmaceutical products.

 

 

Products :

Complex and high margins molecules (APIs/Intermediates), formulations, diagnostics and Over the Counter (OTC) products.

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

 

Products :

Loratadine

Countries :

  • USA
  • Germany

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Cash, Cheque and Credit (60 days / 90 days)

 

 

Purchasing :

Cash, Cheque and Credit (60 days / 90 days)

 

PRODUCTION STATUS : NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Retailers, End Users and OEMs

 

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

1010 (Approximately)

 

 

Bankers :

Bank Name

  • ICICI Bank
  • Punjab National Bank

Branch

Not Divulged

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

Facilities :

SECURED LOANS

31.03.2015

(Rs. In Million)

31.03.2014

(Rs. In Million)

LONG TERM BORROWINGS

 

 

Term Loans from Banks & Institutions

 

 

Restructured Debts -

 

 

Interest Bearing

NA

301.800

Interest Free

NA

444.100

Other Loans

NA

0.600

 

 

 

SHORT TERM BORROWINGS

 

 

From banks

 

 

Buyer's credit facility

[The buyers' credit facility is secured by way of term deposits with the bank.]

NA

11.900

 

 

 

Total

NA

758.400

 

NOTE [AS ON 31.03.2014]

 

LONG TERM BORROWINGS

 

Term Loans from Banks & Institutions

a. Term loans, except noted at (d) below, are secured by a first charge created by way of a joint equitable mortgage on pari-passu basis on all immovable and movable fixed assets, including plant and machinery, land & buildings and others, both present and future, first charge over Escrow/Trust and Retention Account, and second charge on the current assets of the company, both present and future. Further these loans are secured by personal guarantee of Managing Director of the company.

 

b. Yearwise re-payment schedule of Interest bearing portion of term loans, payable in quarterly instalments is as under –

 

Year of Repayment

2015-16

2016-17

2017-18

Total

Annual Repayment Amount

124.200

88.800

88.800

301.800

Annual Rate of Interest

18%

18%

18%

--

 

c. Yearwise re-payment schedule of Interest free portion of term loans, payable in quarterly instalments is as under. Debt is interest free till March, 2015.

 

Year of Repayment

2015-16

2016-17

2017-18

Total

Annual Repayment Amount

--

111.000

333.100

444.100

Annual Rate of Interest

--

8.25%

8.25%

--

 

d. Other loans represents vehicle loans, repayable on monthly basis, are secured by way of hypothecation of specific assets purchased under the hire purchase scheme

 

Year of Repayment

2015-16

2016-17

Total

Annual Repayment Amount

0.500

0.100

0.600

Annual Rate of Interest

8.50% -11.00%

8.50% -11.00%

--

 

e. Details of delay in repayment of term loan & interest thereon is as under –

 

Particulars

Amount

Period

Principal

15.700

Less than 3 Months

Interest

18.200

Less than 3 Months

 

 

 

Financial Institution :

The Oriental Insurance Company Limited, Oriental House, Post Bag No. 7037, A- 25/27, Asaf Ali Road, New Delhi - 110002, India

 

 

Auditors :

 

Name :

M. Kamal Mahajan and Company

Chartered Accountants

Address :

SCO 61, Madhya Marg, Sector 26, Chandigarh, India

 

 

Memberships :

--

 

 

Collaborators :

---

 

 

Subsidiary Companies

[AS ON 31.03.2014] :

MorepenMax Inc. - Overseas Company

Morepen Inc. - Overseas Company

Dr. Morepen Limited - Domestic Company

Total Care Limited - Domestic Company

 

 

Associates

[AS ON 31.03.2014]:

Morepen Biotech Limited - Domestic Company

 

 

Entities over which key management personnel/ or Relatives of key management personnel are able to exercise significant influence with which the

company has any transactions during the year

[AS ON 31.03.2014]:

Blue Coast Infrastructure Development Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2015

 

Authorised Capital : Not Available

 

Issued, Subscribed & Paid-up Capital : Rs.2096.107 Million

 

AS ON 31.03.2014

 

Authorised Capital:

No. of Shares

Type

Value

 

Amount

 

 

 

 

45,00,00,000

Equity Shares

Rs.2/- each

Rs.900.000 Million

1,20,00,000

Preferences Shares

Rs.100/- each

Rs.1200.000 Million

 

 

 

 

 

Total

 

Rs.2100.000 Million

 

Issued & Subscribed Capital:

No. of Shares

Type

Value

 

Amount

 

 

 

 

44,98,26,203

Equity Shares

Rs.2/- each

Rs.899.700 Million

97,35,201

0.01% Optionally Convertible Preference Share

Rs.100/- each

Rs.973.500 Million

17,30,000

0.01% Cumulative Redeemable Preference Shares

Rs.100/- each

Rs.173.000 Million

5,00,000

9.75% Cumulative Redeemable Preference

Shares

Rs.100/- each

Rs.50.000 Million

 

 

 

 

 

Total

 

Rs.2096.200 Million

 

Issued, Subscribed & Paid-up Capital:

No. of Shares

Type

Value

 

Amount

 

 

 

 

44,97,93,203

Equity Shares

Rs.2/- each

Rs.899.600 Million

97,35,201

0.01% Optionally Convertible Preference Share

Rs.100/- each

Rs.973.500 Million

17,30,000

0.01% Cumulative Redeemable Preference Shares

Rs.100/- each

Rs.173.000 Million

5,00,000

9.75% Cumulative Redeemable Preference

Shares

Rs.100/- each

Rs.50.000 Million

 

 

 

 

 

Total

 

Rs.2096.100 Million

 

NOTE:

 

Reconciliation of the numbers and amount of Equity shares.

 

Particulars

31.03.2014

Nos.

Amount in Million

Outstanding at beginning of the year

449826203

899.700

Add : Shares issued during the year

--

--

Less : Shares bought back during the year

--

--

Outstanding at the end of year

449826203

899.700

 

Reconciliation of the numbers and amount of Preference shares –

 

Particulars

31.03.2014

Nos.

Amount in Million

Outstanding at beginning of the year

11965201

1196.500

Add : Shares issued during the year

--

--

Less : Shares bought back during the year

--

--

Outstanding at the end of year

11965201

1196.500

 

Rights, preferences and restrictions attached to each class of Shares and terms of redemption

 

Rights, preferences and restrictions attached to each class of Shares and terms of redemption

 

a) i) The company has two classes of shares referred as equity shares and preference shares. The equity shares are having a par value of Rs. 2/- each whereas par value for each preference shares is Rs. 100/-. Every holder of equity shares is entitled to one vote per share in respect of all matters submitted to vote in the shareholders' meeting. Preference shareholders are entitled to one vote per share, in respect of every resolution placed before the company which directly affect the rights attached to their shares. However, a cumulative preference shareholder acquires voting rights at par with an equity shareholder if the dividend on preference shares has remained unpaid for a period of not less than two years.

 

ii) In the event of liquidation of the company, the holders of equity shares will be entitled to receive the remaining assets of the company after distribution of preferential amounts. The distribution will be in the proportion of the number of equity shares held by the shareholders.

 

iii) 1730000, 0.01% Redeemable Preference Shares of Rs. 100/- each and 500000, 9.75% Redeemable Preference Shares of Rs. 100/- each are cumulative. Dividend arrears on these shares as at 31.03.2014 are Rs. 58.600 Million (Previous year Rs. 53.700 Million).

 

b) i) Out of 97,35,201, 0.01% Optionally Convertible Preference Shares, Shares amounting to Rs. 704.000 Million fall due for redemption/conversion on May 4, 2014, shares amounting to Rs. 176.200 Million are due for redemption on May 31, 2014 whereas balance shares amounting to Rs. 93.300 Million are due for redemption/conversion on February 9, 2015. The conversion, if opted for, of preference shares into equity shares will be at price determined as per SEBI guidelines. Dividend arrears on above preference shares as at 31.03.2014 are Rs. 0.700 Million (Previous year Rs. 0.600 Million).

 

ii) Out of 17,30,000, 0.01% Cumulative Redeemable Preference Shares, 15,30,000 Shares amounting Rs. 153.000 Million are redeemable in two equal instalments, on May 4, 2016 and May 4, 2017. Balance 200000 Shares amounting Rs. 20.000 Million, had already become due for redemption in the financial year ending 31.03.2012, could not be redeemed because of unavailability of surplus.

 

iii) 5,00,000, 9.75% Cumulative redeemable Preference shares amounting to Rs. 50.000 Million had been due for redemption since March, 2004, however, could not be redeemed because of unavailability of surplus. The subscriber has filed a legal case against the company for the recovery of the sum invested as well as interest thereon. The company has contested the claim of the subscriber and have moved the jurisdictional appellant authorities against the said claim.

 

iv) Capital Redemption Reserve for redemption of Preference Shares could not be created during the year because of unavailability of surplus.

 

 

The company itself being ultimate holding company, therefore, disclosure requirements about its parent company are not applicable in the present case.

 

Shareholders holding more than 5% shares

 

i) Equity Shares

 

Name of Shareholder

31.03.2014

No. of Shares

% of Holding

 

 

 

GL India Mauritius (III) Limited

38530000

8.57

 

 

 

 

ii) Preference Shares

 

a) 9735201, 0.01% Optionally Convertible Redeemable Shares -

 

Name of Shareholder

31.03.2014

No. of Shares

% of Holding

Bank of Nova Scotia

1179000

12.11

Stressed Assets Stabilisation Fund (SASF)

961044

9.87

EXIM Bank

916333

9.41

SICOM

829463

8.52

Punjab National Bank

671522

6.90

Oriental Bank of Commerce

623828

6.41

Dena Bank

593936

6.10

UCO Bank

515900

5.30

 

b) 1730000, 0.01% Cumulative Redeemable Shares –

 

Name of Shareholder

31.03.2014

No. of Shares

% of Holding

Oriental Bank of Commerce

1000000

57.80

Axis Bank Limited

500000

28.90

Blue Sky Securities Private Limited

200000

11.56

 

c) 500000, 9.75% Cumulative Redeemable Shares –

 

Name of Shareholder

31.03.2014

No. of Shares

% of Holding

 

 

 

Jammu and Kashmir Bank Limited

500000

100

 

 

 

 

During last 5 years immediately preceding the balance sheet date, no Equity Share or Preference share has been

issued pursuant to any contract without payment being received in cash. Further the company has neither allotted

any share by way of bonus shares, nor it had bought back any Equity or Preference Share during aforesaid period of 5 years.

 

Disclosure about unpaid calls –

(Rs. In Million)

Unpaid Calls

31.03.2014

By Directors and Officers

--

By Others

0.100

 

No shares have been forfeited by the company during the year.


 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

2096.107

2096.100

2096.100

(b) Reserves & Surplus

1034.660

1146.500

1208.100

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

3130.767

3242.600

3304.200

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

622.242

746.500

944.900

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

17.62

20.500

20.900

(d) long-term provisions

87.087

73.500

67.800

Total Non-current Liabilities (3)

726.949

840.500

1033.600

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

22.332

11.900

0.000

(b) Trade payables

785.520

667.500

549.000

(c) Other current liabilities

328.187

309.100

521.400

(d) Short-term provisions

8.358

7.300

6.800

Total Current Liabilities (4)

1144.397

995.800

1077.200

 

 

 

 

TOTAL

5002.113

5078.900

5415.000

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

2434.253

2888.800

3305.900

(ii) Intangible Assets

5.007

5.900

3.200

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

1179.422

1179.400

1218.100

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

339.347

17.500

15.800

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

3958.029

4091.600

4543.000

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

353.631

329.100

367.500

(c) Trade receivables

484.452

400.900

365.900

(d) Cash and cash equivalents

85.985

80.700

47.200

(e) Short-term loans and advances

88.908

140.700

60.100

(f) Other current assets

31.108

35.900

31.300

Total Current Assets

1044.084

987.300

872.000

 

 

 

 

TOTAL

5002.113

5078.900

5415.000

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

31.03.2014

31.03.2013

 

SALES

 

 

 

 

 

Revenue from operations

3702.623

3359.700

3033.500

 

 

Other Income

13.617

7.900

26.200

 

 

TOTAL                                    

3716.240

3367.600

3059.700

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

1452.267

1309.900

1314.700

 

 

Purchases of Stock-in-Trade

832.211

679.100

583.900

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

20.663

16.100

15.700

 

 

Employees benefits expense

435.237

396.800

349.700

 

 

Power and Fuel

74.145

0.000

0.000

 

 

Travelling Expenses

57.405

0.000

0.000

 

 

Selling and Distribution Expenses

160.589

0.000

0.000

 

 

Other expenses

204.251

499.700

479.700

 

 

Extraordinary Items - Income

0.000

(29.000)

(30.800)

 

 

TOTAL                                    

3236.768

2872.600

2712.900

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

479.472

495.000

346.800

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

86.330

98.900

116.100

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

393.142

396.100

230.700

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION        

385.949

457.700

457.400

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

7.193

(61.600)

(226.700)

 

 

 

 

 

Less

TAX                                                                 

1.370

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

5.823

(61.600)

(226.700)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Exports of Goods on F.O.B. basis

NA

1089.800

986.000

 

TOTAL EARNINGS

NA

1089.800

986.000

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

NA

469.100

518.100

 

 

Stock -in -trade

NA

17.100

50.500

 

 

Capital Goods

NA

0.000

6.300

 

TOTAL IMPORTS

NA

486.200

574.900

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

0.002

(0.150)

(0.490)

 

Expected Sales ( 2015-2016 ) : Rs.4100.000 Million

 

The above information has been parted by Mr. Rajiv Jain

 

 

CURRENT MATURITIES OF LONG TERM BORROWINGS DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term borrowings

NA

131.900

165.100

Cash generated from operations

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

0.16

(1.83)

(7.47)

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

12.95

14.73

11.43

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

0.19

(1.58)

(5.40)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.00

(0.02)

(0.07)

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.21

0.23

0.29

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.91

0.99

0.81

 

STOCK PRICES

 

Face Value

Rs.2.00/-

Market Value

Rs.11.85/-

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

2096.100

2096.100

2096.107

Reserves & Surplus

1208.100

1146.500

1034.660

Share Application money pending allotment

0.000

0.000

0.000

Net worth

3304.200

3242.600

3130.767

 

 

 

 

long-term borrowings

944.900

746.500

622.242

Short term borrowings

0.000

11.900

22.332

Total borrowings

944.900

758.400

644.574

Debt/Equity ratio

0.286

0.234

0.206

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

3033.500

3359.700

3702.623

 

 

10.753

10.207

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

3033.500

3359.700

3702.623

Profit/Loss

(226.700)

(61.600)

5.823

 

(7.47%)

(1.83%)

0.16%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

----

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

No

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

---

33

Market information

---

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

CONTINGENT LIABILITIES:

 

PARTICULARS

31.03.2015

(Rs. In Million)

31.03.2014

(Rs. In Million)

Claim against the Company not acknowledged as debts

NA

114.400

Guarantees

NA

0.900

Other money for which company is contingently liable

NA

147.700

Arrears of Fixed Cumulative Dividends on Preference Shares

NA

59.300

Bills discounted with banks

NA

12.600

Total

NA

334.900

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10568955

28/04/2015

637,000.00

PUNJAB NATIONAL BANK

PARWANOO-2912, HIMACHAL PRADESH, HIMACHAL PRADESH 
- 173220, INDIA

C53423471

2

10485469

27/02/2012

950,000.00

THE KARUR VYSYA BANK LIMITED

B 3, LAWERENCE ROAD, DELHI, DELHI - 110035, INDIA

B39243274

3

10344030

10/02/2012

10,783,948.00

THE ORIENTAL INSURANCE COMPANY LIMITED

ORIENTAL HOUSE, POST BAG NO. 7037, A- 25/27, ASAF 
ALI ROAD, NEW DELHI, DELHI - 110002, INDIA

B35754480

4

10345702

10/02/2012

113,134,000.00

THE KARUR VYSYA BANK LIMITED

CENTRAL PROCESSING CELL REPRESENT FORT MUMBAI BR, 
KAMANWALA CHAMBERS,SIR P.M.ROAD,FORT, MUMBAI, MAH 
ARASHTRA - 400001, INDIA

B36353001

5

10342382

10/02/2012

300,000,000.00

EXPORT-IMPORT BANK OF INDIA

FLOOR 21, CENTRE ONE BUILDING, WORLD TRADE CENTRE, 
CUFFE PARADE, MUMBAI, MAHARASHTRA - 400005, INDI 
A

B35095363

6

10342331

10/02/2012

464,310,000.00

UCO BANK

FLAGSHIP CORPORATE CENTRE, 5, PARLIAMENT STREET, 
NEW DELHI, DELHI - 110001, INDIA

B35071026

7

80025870

10/01/2003

5,000,000.00

THE SARASWAT CO-OP. BANK LIMITED

WORLI BRANCH, MUMBAI, MAHARASHTRA - 400018, INDIA

-

8

80025869

08/01/2003

150,000,000.00

SICOM LIMITED

NIRMAL, FIRST FLOOR, NARIMAN POINT, MUMBAI, MAHAR 
ASHTRA - 400021, INDIA

-

9

90169748

13/01/2003 *

150,000,000.00

SICOM LIMITED

NIRMAL 1ST FLOOR, NARIMAN POINT, MUMBAI, MAHARASH 
TRA - 400021, INDIA

-

10

80025868

23/08/2002

150,000,000.00

THE KARUR VYSYA BANK LIMITED

KAMANWALA CHAMBERS, GROUND FLOOR, SIR P.M. ROAD, 
FORT, MUMBAI, MAHARASHTRA - 400001, INDIA

-

 

* Date of charge modification

 

MANAGEMENT OVERVIEW [AS ON 31.03.2014]

 

The company has recorded revenues of Rs. 3367.600 Million during the current financial year against last year revenues of Rs. 3059.700 Million, recording a growth of 10% over the previous year revenues. Operating revenue for the current year at Rs. 3359.700 Million has posted a growth of 10.8% over the last year. Sales revenues of the company are steadily improving over the past few years.

 

Better planning, improved productivity and the effective cost control have helped the company to substantially improve its operating margins in the current year.

 

Growth in Active Pharmaceutical Ingredients (API) business has been moderate, though export price realisation was better on account of weak Indian Rupee against US Dollar. Home Diagnostics and branded formulation business has shown significant improvement in their sales revenues recording a growth of 21% and 27% respectively.

 

Current year's operating surplus of Rs. 466.000 Million has translated into a growth of 48% against last year of Rs. 316.000 Million. Finance cost at Rs. 98.900 Million has come down by 15% against Rs. 116.100 Million incurred in the previous year.

 

Cash generated during the year stands at Rs. 367.100 Million against Rs. 199.900 Million generated during the last financial year.

 

The management is committed towards profitable growth of all its business segments by improving their operating and financial performance. It is committed for the timely servicing of its financial obligations.

 

FIXED ASSETS

 

  • Free hold Land
  • Leasehold Land
  • Buildings
  • Plant and Machinery
  • Furniture’s and Fixtures
  • Vehicles
  • Office Equipment’s
  • Computer Software

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs.63.39

UK Pound

1

Rs.98.94

Euro

1

Rs.70.33

 

 

INFORMATION DETAILS

 

Information Gathered by :

MNJ

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

SNT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

2

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILITY

1~10

--

--LIQUIDITY

1~10

2

--LEVERAGE

1~10

2

--RESERVES

1~10

2

--CREDIT LINES

1~10

---

--MARGINS

-5~5

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

YES

--EPF

YES/NO

NO

TOTAL

 

14

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.